Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 8, 2012 - Issue 7
Submit an article Journal homepage
627
Views
12
CrossRef citations to date
0
Altmetric
Reviews

The pharmacogenetics of β-adrenergic receptor antagonists in the treatment of hypertension and heart failure

Sze Wa ChanThe Chinese University of Hong Kong, The Prince of Wales Hospital, Division of Clinical Pharmacology, Department of Medicine and Therapeutics, Shatin, Hong Kong, SAR China
,
Miao HuThe Chinese University of Hong Kong, The Prince of Wales Hospital, Division of Clinical Pharmacology, Department of Medicine and Therapeutics, Shatin, Hong Kong, SAR China
&
Brian TomlinsonThe Chinese University of Hong Kong, The Prince of Wales Hospital, Division of Clinical Pharmacology, Department of Medicine and Therapeutics, Shatin, Hong Kong, SAR China;The Chinese University of Hong Kong, The Prince of Wales Hospital, Department of Medicine and Therapeutics, Shatin, Hong Kong, SAR China+852 2632 3139; +852 2632 3139; [email protected]
(Professor)
Pages 767-790 | Published online: 24 May 2012

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Christian Höcht, Facundo M. Bertera, Yanina Santander Plantamura, Luciano Parola, Julieta S. Del Mauro & Ariel H. Polizio. (2019) Factors influencing hepatic metabolism of antihypertensive drugs: impact on clinical response. Expert Opinion on Drug Metabolism & Toxicology 15:1, pages 1-13.
Read now
Grazia Daniela Femminella, Vincenzo Barrese, Nicola Ferrara & Giuseppe Rengo. (2014) Tailoring therapy for heart failure: the pharmacogenomics of adrenergic receptor signaling. Pharmacogenomics and Personalized Medicine 7, pages 267-273.
Read now

Articles from other publishers (10)

Gisele Facholi Bomfim, Stefany Bruno Assis Cau, Alexandre Santos Bruno, Aline Garcia Fedoce & Fernando S Carneiro. (2018) Hypertension: a new treatment for an old disease? Targeting the immune system. British Journal of Pharmacology 176:12, pages 2028-2048.
Crossref
L. K. K. Lee, P. N. W. Tsai, K. Y. Ip & M. G. Irwin. (2019) Pre-operative cardiac optimisation: a directed review. Anaesthesia 74, pages 67-79.
Crossref
Langdong Chen, Yan Cao, Hai Zhang, Diya Lv, Yahong Zhao, Yanjun Liu, Guan Ye & Yifeng Chai. (2018) Network pharmacology-based strategy for predicting active ingredients and potential targets of Yangxinshi tablet for treating heart failure. Journal of Ethnopharmacology 219, pages 359-368.
Crossref
D. Wong, P.N.W. Tsai, K.Y. Ip & M.G. Irwin. (2018) New antihypertensive medications and clinical implications. Best Practice & Research Clinical Anaesthesiology 32:2, pages 223-235.
Crossref
Gheorghe-Andrei Dan, Antoni Martinez-Rubio, Stefan Agewall, Giuseppe Boriani, Martin Borggrefe, Fiorenzo Gaita, Isabelle van Gelder, Bulent Gorenek, Juan Carlos Kaski, Keld Kjeldsen, Gregory Y H Lip, Bela Merkely, Ken Okumura, Jonathan P Piccini, Tatjana Potpara, Birgitte Klindt Poulsen, Magdi Saba, Irina Savelieva, Juan L Tamargo, Christian Wolpert, Christian Sticherling, Joachim R Ehrlich, Richard Schilling, Nikola Pavlovic, Tom De Potter, Andrzej Lubinski, Jesper Hastrup Svendsen, Keong Ching, John Lewis Sapp, Carol Chen-Scarabelli & Felipe Martinez. (2018) Antiarrhythmic drugs–clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP). EP Europace 20:5, pages 731-732an.
Crossref
Fannie Mottet, Orly Vardeny & Simon de Denus. (2016) Pharmacogenomics of heart failure: a systematic review. Pharmacogenomics 17:16, pages 1817-1858.
Crossref
Tibebe Woldemariam. 2016. Applying Pharmacogenomics in Therapeutics. Applying Pharmacogenomics in Therapeutics 181 200 .
Payman Shahabi & Marie-Pierre Dubé. (2015) Cardiovascular pharmacogenomics; state of current knowledge and implementation in practice. International Journal of Cardiology 184, pages 772-795.
Crossref
Rodney J. Y. Ho & Milo Gibaldi. 2013. Biotechnology and Biopharmaceuticals. Biotechnology and Biopharmaceuticals 471 494 .
Julie A. Johnson & Larisa H. Cavallari. (2013) Pharmacogenetics and Cardiovascular Disease—Implications for Personalized Medicine. Pharmacological Reviews 65:3, pages 987-1009.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.